Literature DB >> 2896637

Applications of BOP reagent in solid phase synthesis. Advantages of BOP reagent for difficult couplings exemplified by a synthesis of [Ala 15]-GRF(1-29)-NH2.

A Fournier1, C T Wang, A M Felix.   

Abstract

The BOP reagent [benzotriazol-l-yl-oxy-tris-(dimethylamino)phosphonium hexa-fluorophosphate] introduced by Castro et al. [Tetrahedron Lett. (1975) 14, 1219-1222] is ideally suited for solid phase peptide synthesis. The rate of coupling using BOP compared favorably to DCC and other methods of activation including the symmetrical anhydride and DCC/HOBt procedures. BOP couplings using the solid phase procedure proceeded more rapidly and to a greater degree of completion for peptide bond formations that were previously determined to be very slow using the conventional DCC method. Stepwise solid phase peptide synthesis using BOP was successfully utilized for the preparation of the (22-29) and (13-29) fragments of [Ala15]-GRF(1-29)-NH2. Single couplings with 3 equiv. BOP and Boc-amino acids and 5.3 equiv. of diisopropylethylamine in DMF were used for each cycle. The yields of the fragments were superior and the purities comparable using the BOP procedure (single couplings) to those observed using multiple couplings via the DCC coupling method. A total synthesis of [Ala15]-GRF(1-29)-NH2 was also carried out using the BOP procedure (single couplings and 3 equiv. BOP and Boc-amino acids and 5.3 equiv. diisopropylethylamine in DMF for each cycle). Multiple couplings were only required for Boc-Asn-OH due to the proposed formation of Boc-aminosuccinimide during activation. The resultant GRF(1-29) analog was comparable to a control prepared with multiple DCC couplings under optimized conditions. In a parallel study, unprotected Boc-(hydroxy)-amino acids were successfully coupled with the BOP reagent. However, the number of coupling cycles after the introduction of unprotected hydroxy-amino acid must be minimal (less than 10). The use of the BOP reagent with unprotected Tyr in solid phase peptide synthesis was also clearly established.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2896637     DOI: 10.1111/j.1399-3011.1988.tb00010.x

Source DB:  PubMed          Journal:  Int J Pept Protein Res        ISSN: 0367-8377


  8 in total

1.  Synthetic peptides based upon a three-dimensional model for the receptor recognition site of follicle-stimulating hormone exhibit antagonistic or agonistic activity at low concentrations.

Authors:  M Hage-van Noort; W C Puijk; H H Plasman; D Kuperus; W M Schaaper; N J Beekman; J A Grootegoed; R H Meloen
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

2.  Analysis and simulation of a neutralizing epitope of transmissible gastroenteritis virus.

Authors:  W P Posthumus; J A Lenstra; W M Schaaper; A P van Nieuwstadt; L Enjuanes; R H Meloen
Journal:  J Virol       Date:  1990-07       Impact factor: 5.103

3.  Presynaptic inhibition by neuropeptide Y in rat hippocampal slice in vitro is mediated by a Y2 receptor.

Authors:  W F Colmers; G J Klapstein; A Fournier; S St-Pierre; K A Treherne
Journal:  Br J Pharmacol       Date:  1991-01       Impact factor: 8.739

4.  Introduction to peptide synthesis.

Authors:  Gregg B Fields
Journal:  Curr Protoc Protein Sci       Date:  2002-02

5.  Neuropeptide Y inhibits Ca2+ influx into cultured dorsal root ganglion neurones of the rat via a Y2 receptor.

Authors:  D Bleakman; W F Colmers; A Fournier; R J Miller
Journal:  Br J Pharmacol       Date:  1991-07       Impact factor: 8.739

6.  Proliferative lymphocyte responses to foot-and-mouth disease virus and three FMDV peptides after vaccination or immunization with these peptides in cattle.

Authors:  M J van Lierop; K van Maanen; R H Meloen; V P Rutten; M A de Jong; E J Hensen
Journal:  Immunology       Date:  1992-03       Impact factor: 7.397

7.  New Gaba-containing analogues of human growth hormone-releasing hormone (1-30)-amide: I. Synthesis and in vitro biological activity.

Authors:  I Mezö; M Kovács; B Szöke; E Z Szabó; J Horváth; G B Makara; G Rappay; J Tamás; I Teplán
Journal:  J Endocrinol Invest       Date:  1993-11       Impact factor: 4.256

8.  Characterization of murine coronavirus neutralization epitopes with phage-displayed peptides.

Authors:  M W Yu; J K Scott; A Fournier; P J Talbot
Journal:  Virology       Date:  2000-05-25       Impact factor: 3.616

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.